Comparison of protective effects of omega3 fish oil and aqueous extract of Glycyrrhiza glabra root on biochemical factors and liver tissue changes induced by thioacetamide in male rats by Moghadamnia, D. et al.
Advanced Herbal Medicine, 2016; 2(1): 7-19. 
*
Corresponding author: Mokhtar Mokhtari, Biology Dept., Kazerun Branch, Islamic Azad University, Kazerun, 
I.R. Iran, Tel: 00989171811963, E-mail: m.mokhtari246@yahoo.com 
7 
 
herbmed.skums.ac.ir 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
O
rig
in
a
l a
rticle 
Comparison of protective effects of omega3 fish oil and aqueous 
extract of Glycyrrhiza glabra root on biochemical factors and liver 
tissue changes induced by thioacetamide in male rats 
 
Davood Moghadamnia
1,2
, Mokhtar Mokhtari
3*
, Saeed Khatamsaz
3
 
1
Biology Dept., Fars Science and Research Branch, Islamic Azad University, Fars, I.R. 
Iran; 
2
Biology Dept., Shiraz Branch, Islamic Azad University, Shiraz, I.R. Iran; 
3
Biology 
Dept., Kazerun Branch, Islamic Azad University, Kazerun, I.R. Iran. 
Received: 9/Feb/2016 Accepted: 25/Apr/2016 
 
ABSTRACT 
Background and aims: Thioacetamide can lead to liver cirrhosis and hepatocarcinoma. This 
study was aimed to evaluate the ability of omega3 fish oil and Glycyrrhiza glabra aqueous 
extract to attenuate biochemical factors and liver tissue changes induced by thioacetamide. 
Methods: In this experimental study, 63 wistar male rats were divided into 9 groups. Control 
group, Sham group received 0.4ml olive oil orally per day for 3 months. Thioacetamide group 
received 150 mg/kg of TAA intraperitoneally in a single dose for 3 months. Experimental 
groups 1, 2, 3, 4, 5 and 6 received 100, 200, 300 mg/kg of omega3 fish oil and aqueous 
extract of Glycyrrhiza glabra root orally per day for 3 months and 150 mg/kg of TAA 
intraperitoneally in a single dose for 3 months. The provided blood samples were tested for 
serum levels of bilirubin, albumin, and total protein. The pathological examination of hepatic 
tissue samples was done after hematoxylin and eosin staining. 
Results: Treatment with 100 mg/kg of omega3 fish oil (0.06±0.013) significant reduced 
the serum level of billirubin comparing with thioacetamide group (0.38±0.015). 
Treatment with the aqueous extract of Glycyrrhiza glabra root at all doses (0.37±0.034) 
(0.34±0.027) (0.15±0.028) showed no significant difference in the serum level of 
billirubin comparing with thioacetamide group (0.38±0.015). Treatment with the omega3 
fish oil (4.40±0.02) (4.32±0.10) (4.34±0.10) and aqueous extract of Glycyrrhiza glabra 
root at all doses (4.33±0.06) (4.31±0.5) (4.20±0.07) significant reduced the serum level of 
albumin comparing with thioacetamide group (4.70±0.00). The mean levels of total protein 
showed no significant difference in the experimental groups (8.77±0.31) (8.53±0.20) 
(8.63±0.24) (8.58±0.05) (8.57±0.10) (7.92±0.21) comparing with thioacetamide group 
(8.56±0.08). In all experimental groups, the hepatic tissue changes induced by 
thioacetamide improved which were dose dependent (P<0.05). 
Conclusion: The study suggests that biochemical factors and liver tissue changes 
induced by thioacetamide in male rats can be ameliorated by oral administration of 
aqueous extract of Glycyrrhiza glabra root and omega3 fish oil. 
 
Keywords: Glycyrrhiza glabra root, Omega3 fish oil, Thioacetamide, Biochemical 
factors, Rat. 
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INTRODUCTION
Liver plays a crucial role in the 
metabolic elimination of most drugs and 
foreign compounds. Thus, it makes an 
important target for toxicities. Liver 
diseases such as hepatocellular carcinoma, 
viral and alcoholic hepatitis and  
non-alcoholic steatosis are the most 
common liver-associated and prevalent 
diseases in the world which are closely 
associated with jaundice.
1
 TAA is known to 
be hepatotoxic and carcinogenic compound 
in animals and most likely in humans. 
The cirrhosis model induced by TAA 
in rats produces histopathological changes 
that are similar to those found in humans 
and animals.
2
 The toxicity of TAA results 
from its bioactivity by mixed-function 
oxidase system, particularly CYP2E1 and 
FAD monooxygenase.
2-4
 Metabolic 
activation of TAA then leads to the 
formation of reactive metabolites that are 
represented by radicals derived from 
thioacetamide-s-oxide and by reactive 
oxygen species (ROS) generated as 
intermediates.
5
 
The omega3 fatty acids has beneficial 
effects in preventing atherosclerotic 
diseases and insulin resistances in adipose 
tissue.
6
 Omega3 fatty acid treatment may 
have beneficial effects in regulating hepatic 
lipid metabolism, adipose tissue function. 
Omega3 fatty acids may be useful in the 
treatment of nonalcoholic steatohepatitis.
7
 
Eicosapentaenoic acid improves glycemic 
control in elderly bedridden patients with 
type2 diabetes.
8
 
Omega3 improves cardiovascular 
disorders
9
, psychiatric disease
10,11
, 
inflammatory bowel disease
12 
and cystic 
fibrosis.
13-15
 Omega 3 fatty acids were shown 
to attenuate growth and induce apoptosis in a 
variety of human cancer lines derived from 
colonic, pancreatic prostate, and breast 
cancer.
16
 According to Li et al. consumption 
of diet containing fish oil can reduce systemic 
inflammation and liver damage induced by 
infection through up-regulation of the 
peroxisome proliferator-activated receptor 
gamma-mediated pathway (PPAR) in septic 
mice.
17
 Also, Jangale et al. determined that 
fish oil and flax seed oil can alleviate 
inflammation in diabetic mice induced by 
streptozotocin-nicotinamide.
18
 Kim et al. 
showed that diet containing Omega-3 can 
attenuate hepatic damage caused by ischemia 
and tissue reperfusion via reduction of NF-Kb 
activity.
19
 
Glycyrrhiza glabra is one of the most 
widely used herbs from the ancient medical 
history of Ayurreda, both as a medicine 
herb. It is a sweet, moist, soothing herb that 
detoxifies and protects the liver and is also 
a powerful anti-inflammatory, and is used 
in conditions as varied , arthritis and mouth 
ulcers. Root of Glycyrrhiza glabra 
contained glycyrrhizin, flavonoid rich 
fraction include liquirtin, isoliquirtigenin
20
 
and other constituents such as coumarins, 
pectin, tanins, phytosterols, choline and 
various other substance.
21
 
Many biological activities such as 
antitumor promote activity, and antimicrobial 
effects.
22,23
 The combination of Silybum 
marianum (silymarin) and Glycyrrhiza 
glabra (Glycyrrhizin) in different doses has 
protective effect against oxidative stress in 
the liver.
24
 The saponins from the root of 
Glycyrrhiza inflata have protective impacts 
on hepatic cells of rats intoxicated by  
D-galactosamine through reducing the levels 
of ALT and AST liver enzymes.
25
 
Regarding the anti-inflammatory and 
antioxidant effects of omega3 fish oil and 
Glycyrrhiza glabra root and its long use 
for the treatment of liver disorders, the 
protective effect of omega3 fish oil and 
aqueous extract of Glycyrrhiza glabra root 
on biochemical factors and liver tissue 
changes induced by thioacetamide in male 
rats. 
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METHODS 
In this experimental study, 63 adult male 
wistar rats in a weight range of 200±10 g and 
the age range of 2.5±3 months were used. 
Animals were randomly divided in 9 groups 
of seven, and kept under standard conditions 
of 20-22 °C and light cycle of 12 h and 12 h 
dark. They had easy access to food and water, 
and all ethical considerations and animal 
rights were ensured. 
Animals were divided into 9 equal groups 
and were treated as follow: the control group 
which was left untreated and subjected to no 
stress; the sham which daily received 0.4ml/kg 
olive oil as a solvent  fish oil omega3; the 
thioacetamide group which received a single 
dose of 150 mg/kg thioacetamide; the 
experimental groups 1, 2 and 3 received a 
daily dose of 100, 200 and 300 mg/kg fish oil 
omega-3, respectively followed by a single 
dose of 150 mg/kg thioacetamide. 
Experimental group 4: animals in this group 
received 100 mg/kg of Glycyrrhiza glabra 
root aqueous extract orally for 3 months and a 
single intraperitoneal injection of 
thioacetamide at a dose of 150 mg/kg at the 
end of 3 months. The experimental group 5: 
animals in this group received 200 mg/kg of 
Glycyrrhiza glabra root aqueous extract daily 
orally for 3 months and a single 
intraperitoneal injection of thioacetamide at a 
dose of 150 mg/kg at the end of 3 months. The 
experimental group 6: animals in this group 
daily received 300 mg/kg of Glycyrrhiza 
glabra root aqueous extract orally for  
3 months and a single intraperitoneal injection 
of thioacetamide at a dose of 150 mg/kg at the 
end of the 3 months period. Fish oil omega3 
and Glycyrrhiza glabra root aqueous extract 
was administered orally for 3 months, and 
thioacetamide was injected interperitonaly at 
the end of treating period. 
48 hours after the last injection, animals 
were anesthetized with ether, and blood 
samples were taken from the heart. These 
samples were kept under laboratory 
conditions for 20 minutes; then, centrifuged 
at 5000 RPM for 15 minutes.
26,27
 
As the effects of toxic thioacetamide 
usually become apparent about 2 days after 
injection, 48 h after the last injection all 
animals were anesthetized with ether 
(Merck, Germany), and their blood samples 
were directly taken from the heart. 
The obtained blood samples were kept 
under laboratory conditions for 20min and 
then were centrifuged at 5000 rounds per 
minute for 15 min (Hettich, Germany).
28,29
 
To measure bilirubin, azo DVD 
reagents (sulfanilic acid sodium nitrite) were 
used; they react with bilirubin, producing 
azo, which is red in alkaline PH. After 
production, direct bilirubin has a pink color, 
but after addition of accelerating solution, 
total bilirubin turns green in alkaline PH. To 
measure the total protein biuret reaction end 
point (by Diasys, Germany) was used in 
which in an alkaline environment proteins 
reacted with copper ions and tartrate and 
formed azure color whose density was 
proportional to the amount of total protein in 
the sample. For measuring albumin, 
bromocresol green method (Diasys, 
Germany) was used in which, albumin with 
bromocresol produced a colored complex 
whose color intensity was proportional to 
the amount of albumin in the sample.
30 
After removal, livers were fixed 
separately in 10% neutral formalin buffer. 
Following histological tissue preparation 
and producing specimen blocks, 4-5 micron 
thick sections were prepared. Using 
hematoxylin-eosin method was stained and 
studied by light microscope. 
SPSS software (version 18, Chicago, IL, 
USA) was used for data analysis. The 
ANOVA test was performed on the data. 
Tukey test was used to evaluate the significant 
differences of the data (Tukey-HSD) and all 
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the differences were considered as significant 
at P≤0.05. The plasma concentration of total 
protein, albumin and bilirubin were presented 
as mean±SE.
31
 
 
RESULTS 
In addition, the serum concentration 
mean of bilirubin rose significantly in the 
thioacetamide group (0.38±0.015) compared 
to control and sham groups (0.12±0.015) 
(0.23±0.029) while it showed no significant 
change in all experimental groups receiving 
omega3 fish oil (0.06±0.013) (0.010±0.17) 
(0.14±0.026) compared to control and sham 
groups (0.12±0.015) (0.23±0.029), but a 
significant decline was seen between all three 
experimental groups receiving omega3 fish 
oil (0.06±0.013) (0.010±0.17) (0.14±0.026), 
and the group receiving thioacetamide 
(0.38±0.015) (P≤0.05). (Figure 1). 
The average concentration of bilirubin in 
all experimental groups which received 
aqueous extract of Glycyrrhiza glabra root 
and thioacetamide (0.37±0.034) 
(0.34±0.027) (0.15±0.028) showed a 
significant decrease when it was compared 
to that in the group which received 
thioacetamide (0.38±0.015), and it was not 
significant yet. The average concentration 
of serum bilirubin in the experimental 
groups receiving 200, 300 mg/kg of 
aqueous extract of Glycyrrhiza glabra root 
and thioacetamide) (0.34±0.027) 
(0.15±0.028) had a significant increase 
when it was compared to the control and 
sham groups (0.12±0.015) (0.23±0.029) 
(P≤0.05). (Figure 1). 
 
 
Figure 1: Effects of different doses of omega3 fish oil and aqueous extract of Glycyrrhiza 
glabra root on serum levels of billirubin 
Letter a represents significant differences between group receiving thioacetamide alone, and control and sham 
groups at the level of P<0.05. Letter b represents significant differences between thioacetamide group, and various 
experimental groups at the level of P<0.05; and letter c represents significant differences among different 
experimental groups, and control and sham groups at the level of P<0.05. 
 
a 
b 
 
c c 
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Also, in regard to concentrations of total 
proteins, no significant change was observed 
between group receiving thioacetamide, and 
control and sham groups (8.56±0.08) 
(8.88±0.5) (8.56±0.08) as well as between 
various experimental groups receiving 
omega3 fish oil (8.77±0.31) (8.53±0.20) 
(8.63±0.24), and control, sham and 
thioacetamide groups (8.88±0.5) (8.56±0.08) 
(8.56±0.08) (P≤0.05) (Figure 2). 
The average concentration of total 
protein in all experimental groups which 
received Glycyrrhiza glabra root aqueous 
extract and thioacetamide (8.58±0.05) 
(8.57±0.10) (7.92±0.21) showed no 
significant change compared to the group 
receiving thioacetamide (8.56±0.08). The 
mean total protein concentration in the 
experimental group receiving 300mg/kg of 
the aqueous extract of Glycyrrhiza glabra 
root and thioacetamide (7.92±0.21) 
decreased significantly when compared to 
the control and sham groups (8.88±0.5) 
(8.56±0.08) (P≤0.05) (Figure 2). 
 
 
Figure 2: Effects of different doses of omega3 fish oil and aqueous extract of Glycyrrhiza 
glabra root on serum levels of albumin 
Letter a represents significant differences between group receiving thioacetamide alone, and control and sham 
groups at the level of P<0.05; letter b represents significant differences between thioacetamide  group, and various 
experimental groups at the level of P<0.05. 
 
The mean levels of albumen increased 
significantly in group receiving 
thioacetamide (4.70±0.00) compared with 
control and sham groups (4.30±0.04) 
a a b b b b b b 
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(4.30±0.03), whereas it showed no 
significant change in all experimental 
groups receiving omega3 fish oil 
(4.40±0.02) (4.32±0.10) (4.34±0.10) relative 
to control and sham groups (4.30±0.04) 
(4.30±0.03), but a significant decline was 
seen between all three experimental groups 
receiving omega3 fish oil (4.40±0.02) 
(4.32±0.10) (4.34±0.10), and the group 
receiving thioacetamide (4.70±0.00) 
(P≤0.05) (Figure 3). 
The average concentration of albumin in 
all experimental groups which received 
aqueous extract of Glycyrrhiza glabra root 
and thioacetamide (4.33±0.06) (4.31±0.5) 
(4.20±0.07) showed a significant decrease 
when it was compared to the thioacetamide 
group (4.70±0.00) (P≤0.05) (Figure 3). 
 
 
Figure 3: Effects of different doses of omega3 fish oil and aqueous extract of Glycyrrhiza 
glabra root on serum levels of total protein 
Letter a Represents significant differences between group receiving thioacetamide alone, and control and sham 
groups at the level of P<0.05. 
 
Histological studies of hepatic samples 
showed normal hepatocytes with protected 
cytoplasm and marked nuclei in control and 
sham groups (Figures 4-A and 4-B). In 
contrast, tissue sections in thioacetamide 
group in comparison with the control and 
sham groups indicated hepatocyte necrosis, 
increase in mitosis, cell death, abnormal 
mitotic inflammation in portal space and large 
nuclei (Figure 4-C). Although tissue samples 
of the experimental groups 1 and 2 (receiving 
100 and 200 mg/kg omega3 fish oil and 
thioacetamide) showed no hepatocyte mitosis, 
apoptosis and necrosis, they had large nuclei 
(Figures 4-D and 4-E), whereas the 
experimental group 3 (recipient of 300 mg/kg 
omega3 fish oil and thioacetamide) showed 
normal liver tissue (Figure 4-F). 
 
c 
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In the experimental groups 4 and 5 
which received 100 and 200 mg/kg of 
aqueous extract of Glycyrrhiza glabra root 
and thioacetamide cell, necrosis had stopped 
but the nucleus was still large with no 
apoptosis (Figure 4-G and 4-H). The 
experimental group 6 receiving 300 mg/kg 
of aqueous extract of Glycyrrhiza glabra 
root and thioacetamide revealed a normal 
liver tissue. (Figure 4-I). 
 
   
A B C 
   
D E F 
 
  
G H I 
Figure 4: Photomicrograph of liver tissue in different groups (Magnification X40) 
A: Control group; B: Sham group;C: Thioacetamide group (receiving thioacetamide); D: Experimental group 1 
(receiving 100 mg/kg omega3 fish oil and thioacetamide); E: Eexperimental group 2 (receiving 200 mg/kg omega3 
fish oil and thioacetamide); F: Experimental group 3 (receiving 300 mg/kg omega3 fish oil and thioacetamide;  
G: Experimental group 4 (receiving 100 mg/kg of aqueous extract of Glycyrrhiza glabra root and thioacetamide;  
H: Experimental group 5 (receiving 200 mg/kg of aqueous extract of Glycyrrhiza glabra root and thioacetamide);  
I: Experimental group 3 (receiving 300 mg/kg aqueous extract of Glycyrrhiza glabra root and thioacetamide). 
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Figure A shows normal hepatocytes with 
protected cytoplasm, and marked nuclei. 
Figure B shows normal hepatocytes with 
protected cytoplasm and marked nuclei. In 
figure C it shows hepatocyte necrosis, 
increase in mitosis, cell death, abnormal 
mitotic inflammation in portal space and 
large nuclei. Figure D shows no hepatocyte 
mitosis, apoptosis and necrosis, but still 
have large nuclei, and figure E shows no 
hepatocyte mitosis, apoptosis and necrosis, 
but still have large nuclei. Figure F also 
shows regeneration of liver tissue to natural 
state, hepatocytes have normal size nuclei, 
and mitosis and apoptosis are not seen. 
Figure G shows no hepatocyte mitosis, 
apoptosis and necrosis, but still have large 
nuclei. Figure H shows no hepatocyte 
mitosis, apoptosis and necrosis, but still 
have large nuclei. Figure I showing 
regeneration of liver tissue to natural state, 
hepatocytes have normal size nuclei, and 
mitosis and apoptosis are not seen. 
 
DISCUSSION 
Thioacetamide (TAA) was reported as a 
hepatotoxic agent by fitzhugh and nelson.  
A single dose of this toxin in animals can 
produce centrilobular necrosis with a 
subsequent regenerative response.
32,33
 Chronic 
administration can lead to liver cirrhosis and 
hepatocarcinoma.
34-36
 TAA induces 
hepatocyte damage following its metabolism 
to thioacetamide sulphene and sulphone via a 
critical pathway involving cytochrome  
P450-mediated biotransformation.
33
 These 
metabolites are highly reactive and thus lead 
to denaturation of cellular biomolecules such 
as lipids, resulting in lipid peroxidation.
37 
According to the results of this study, 
the values of albumin and bilirubin in 
groups treated with thioacetamide increased 
significantly compared to the control and 
sham groups. The mean serum albumin 
concentration in all experimental groups 
receiving fish oil omega3 and thioacetamide 
significantly decreased compared to the 
thioacetamide group. The average 
concentration of billirubin in the 
experimental groups which received 
100mg/kg of fish oil omega3 and 
thioacetamide showed a significant decrease 
compared to the group receiving 
thioacetamide (P<0.05). This means that the 
fish oil omega-3 had protective effects on 
liver cells against damage caused by 
thioacetamide. The histopathological studies 
also confirmed these results. 
Omega3 with their antioxidant properties 
reduces the toxicity of thioacetamide. The 
antioxidant and anti-inflammatory effects of 
omega3 for scavenging of free radicals and 
inhibiting lipid peroxidation have been 
reported previously.
38
 
The anti-inflammatory action of omega3 
is achieved by reducing the pro-inflammatory 
cytokines like interleukin-1 and tumor 
necrosis factor alpha
39
 and it has effects on 
transcription factor that regulate 
inflammatory gene expression (Nuclear 
factor kappa).
40
 
Omega3 fatty acids may also inhibit 
product of inflammatory and fibrotic 
mediators including C-reactive protein (CRP), 
interleukins (IL), tumor necrosis factor alpha 
(TNF-a), metalloproteina (MMP) 2,9 and 
tissue inhibition of metalloproteinases.
41
 
Omega3 fatty acids regulate the  
TNF-a response to lipopolysaccharide insult. 
It would be seen in sepsis and this may have a 
direct role in hepatoprotection
42
. Omega3 fatty 
acids protection of paracetamol induced liver 
damage by omega3 fatty acids includes 
membrane stabilizing action on the 
hepatocytes.
27
 Omega3 fatty acids could 
ameliorate the toxic effects of 
diethylnitrosamine toxic in part by means of 
free radical scavenging activity and may be 
with therapeutic value in the protection of 
liver against toxic effects of 
diethylnitrosamine.
43
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Omega3 polyunsaturated fatty acid may 
prevent acute liver failure and promotes 
liver regeneration alter 90% hepatectomy in 
rats. Omega3 polyunsaturated fatty acid 
significantly increased interlukin-4 and 
interlukin-10 levels, whereas interlukin-6 
and tumor necrosis factor-a levels 
dramatically decreased.
44
 Administration of 
omega3 fatty acids may reduce infection rate 
and improves liver function recovery in 
HBV-associated hepatocellular carcinoma 
patient after hepatoctomy. This 
improvement is associated with suppressed 
production of proinflammatory cytokines in 
these patients.
45 
In general, the results of this study are 
in line with the results of other studies. It 
seems that the oral administration of fish oil 
omega-3 supplement has protective effect on 
thioacetamide induced liver toxicity by 
neutralizing free radicals, stimulating the 
activity of antioxidant enzymes, and 
reducing the production of inflammatory 
cytokinin. 
The mean serum albumin concentration 
in all experimental groups receiving aqueous 
extract of Glycyrrhiza glabra root and 
thioacetamide significantly decreased 
compared to the thioacetamide group 
(P<0.05). This means that the extract had 
protective effects on liver cells against 
damage caused by thioacetamide. The 
histopathological studies also confirmed 
these results. 
Mitsuton Kimura et al reported that In 
vivo glycyrrhizin accelerates liver 
regeneration and rapidly lowers serum 
transaminase activities in 70% partially 
hepatectomized rats.
46
 Mitsutoshi Kimura et 
al. reported that glycyrrhizin and some 
analogues are primary hepatocyte mitogens 
that bind to EGF receptors and subsequently 
stimulate the receptor tyrosine 
kinase/mitogen-activated protein kinase 
pathway to induced hepatocyte DNA 
synthesis and proliferation.
47
 Glycyrrhetinic 
acid decreases ALT by inhibits the 
enzymatic (11 Beta-hydoxy steroid 
dehydrogenase) conversion of cortisol to 
cortisone and increases cortisol levels. 
Glycyrrhizin inhibit lipopolysaccharide and 
D-galactosamin-induced liver injury 
through preventing inflammatory responses 
and IL-18 production. Glycyrrhizin 
prevents IL-18-mediated inflammation in 
liver injury.
48
 Tripathi et al reported that 
glycyrrhizic acid modulated t-BHP induced 
apoptosis in primary rat hepatocytes.
49
 Jong 
Rok Lee et al. reported that licorice extract 
has hepatoprotective effects by inhibited Bad 
translocation.
50
 Young Woo Kim et al. 
reported that liquiritegenin prevent acute 
liver injuries in rat induced by actaminophen 
with and without buthionine sulfoximine.
51
 
Young Mil Kim et al. reported that 
isoliquirtigenin (ILQ) of Glycyrrhiza glabra 
inhibited oxidative stress as indicated by 
decreasing iNOS, COX2 induction and 
nitrotryosinylation. ILQ protects hepatocyte 
from oxidative injury infected by fat 
accumulation.
52
 Kaku Nakagwa et al. 
reported that licorice flavonoid oil 
concentration solution has a significant 
inhibitory effect on liver carcinogenesis.
53
 
Glycyrrhizinic acid, the major component 
of Glycyrrhiza glabra shows 
hepatoprotective effects by preventing 
changes in cell membrane permeability and 
increasing survival rate of hepatocyte.
54
 
Extract of Glycyrrhiza glabra showed a 
novel hepatoprotective effects against 
diclofenac-induced hepatotoxicity in rats.
55
 
Glycyrrhetinic acid blocks the bioactivity 
of CCL4 by inhibiting the activity of 
P4502E1 thereby preventing the 
hepatoproxidation.
56
 Glycrrhizin is a potent 
chemopreventive compound against lead 
acetate mediated hepatic oxidative stress 
toxicity and tumor promotion related 
responses in rats.
57
 It seems that the oral 
administration of aqueous extract of 
Glycyrrhiza glabra root has protective 
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effect on thioacetamide induced biochemical 
factors and liver tissue by neutralizing free 
radicals, stimulating the activity of 
antioxidant enzymes, and reducing the 
production of inflammatory cytokinin. 
 
CONCLUSION 
In general, the results of present study 
showed that omega3 fish oil and Glycyrrhiza 
glabra aqueous extract could act on liver as 
potential antioxidant to prevent from 
biochemical factors and liver tissue changes 
induced by thioacetamide in male rats. 
Thus, if it is supported by more 
experiments, it is possible to add omega-3 
fish oil and Glycyrrhiza glabra aqueous 
extract to the diet of patients with 
biochemical factors and liver tissue changes. 
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